Drug treatment commissioning and market mechanisms with Alison Ritter
Professor Alison Ritter talks about her recent paper “Are market mechanisms associated with alcohol and other drug treatment outcomes” and about the Australian context of drug treatment provision and commissioning. We discuss the challenges of measuring outcomes against commissioning structures and Professor Ritter explains how funding arrangements can end up looking like a bowl of spaghetti. Alison discusses why governments don’t necessarily have to tender competitively, about the burdens associated with the machinery of recommissioning and about the potential for fixed-price tendering to improve the quality of addiction treatment services.Ritter, A., van de Ven, K., Vuong, T., Chalmers, J., Dobbins, T., Livingston, M. and Berends, L. Are market mechanisms associated with alcohol and other drug treatment outcomes?. Addiction 2021; doi:10.1111/add.15681 https://onlinelibrary.wiley.com/doi/10.1111/add.15681 Hosted on Acast. See acast.com/privacy for more information.
15 Okt 202122min
The Paper Authoring Tool (PAT) with Robert West
Rob Calder talks to Professor Robert West about the Paper Authoring Tool (PAT). Professor West talks about how PAT can be used in the design and write-up phases of a randomised controlled trials, about how it saves time for reviewers and journals and about how using the PAT can make your research more rigorous, well reported and discoverable. He also discusses the future of research publishing and how computer reading can save months or years on evidence synthesis and how this relates to the Human Behaviour Change Project. There is also a small section on the interaction between computers, humans and chess.West, R. PAT: an on‐line paper authoring tool for writing up randomized controlled trials. Addiction 2021; 116: 1938-1940paperauthoringtool.com Hosted on Acast. See acast.com/privacy for more information.
14 Sep 202127min
Cannabis, opioids and the gateway hypothesis with Jack Wilson
Jack Wilson talks to Rob Calder about his recent systematic review and meta-analysis on whether cannabis use increases the likelihood of later life opioid use or opioid use disorders. Jack talks about the limitations of the literature, the influence that the gateway hypothesis has had on policy and on some of the different types of studies that explore this issue. Wilson J, Mills K, Freeman TP, Sunderland M, Visontay R, and Marel C. Weeding out the truth: a systematic review and meta-analysis on the transition from cannabis use to opioid use and opioid use disorders, abuse or dependence. Addiction 2021; doi:10.1111/add.15581 https://onlinelibrary.wiley.com/doi/abs/10.1111/add.15581 Hosted on Acast. See acast.com/privacy for more information.
15 Jul 202116min
Cannabis, schizophrenia and genetics with Emma Johnson
Dr Emma Johnson talks to Rob Calder about shared genetic liabilities for cannabis use disorder and schizophrenia and the role of tobacco smoking. Dr Johnson talks about the implications of this research on the evidence for a causal relationship between cannabis and schizophrenia and for other genetic associations relating to substance use and psychiatric disorders. The episode also covers to ever-fascinating issue of mendelian randomisation. (Be sure to check out episode 22 too!)Johnson E.C., Hatoum A.S., Deak J.D., Polimanti R, Murray R.M., Edenberg H.J., et al. The relationship between cannabis and schizophrenia: a genetically informed perspective. Addiction 2021 https://doi.org/10.1111/add.15534 Hosted on Acast. See acast.com/privacy for more information.
14 Jun 202116min
Pay for Performance funding and emergency hospital admissions with Thomas Mason
Rob Calder talks to Dr Thomas Mason about his research on pay for performance models of addiction treatment and how they were associated with increased emergency hospital admissions. Mason T, Whittaker W, Jones A, Sutton M. Did paying drugs misuse treatment providers for outcomes lead to unintended consequences for hospital admissions? Difference-in-differences analysis of a pay-for-performance scheme in England. Addiction 2021 https://doi.org/10.1111/add.15486 Hosted on Acast. See acast.com/privacy for more information.
1 Jun 202119min
Vaping and smoking cessation with Máirtín McDermott and Leonie Brose
Rob Calder talks to Dr Máirtín McDermott and Dr Leonie Brose about their research into the effectiveness of e-cigarettes for quitting smoking.McDermott M.S, East K.A, Brose L.S, McNeill A, Hitchman S.C, Partos T.R. The effectiveness of using e‐cigarettes for quitting smoking compared to other cessation methods among adults in the United Kingdom. Addiction 2021. https://doi.org/10.1111/add.15474 Hosted on Acast. See acast.com/privacy for more information.
28 Apr 202117min
Alcohol attributable mortality in the Americas with Maristela Monteiro
Rob Calder talks to Dr Maristela Monteiro about deaths in the Americas between 2013 and 2015 that were 100% attributable to alcohol. Chrystoja B.R, Monteiro M.G, Owe G, Pinheiro Gawryszewski V, Rehm J, Shield K. Mortality in the Americas from 2013 to 2015 resulting from diseases, conditions and injuries which are 100% alcohol attributable. Addiction 2021 https://doi.org/10.1111/add.15475 Hosted on Acast. See acast.com/privacy for more information.
12 Apr 202120min
Social norms and smoking behaviour with Katie East
Rob Calder speaks to Dr Katie East about her research into social norms in relation to smoking behaviourEast K, McNeill A, Thrasher JF, Hitchman SC. Social norms as a predictor of smoking uptake among youth: a systematic review, meta‐analysis and meta‐regression of prospective cohort studies. Addiction 2021 https://doi.org/10.1111/add.15427 Hosted on Acast. See acast.com/privacy for more information.
8 Apr 202111min
